Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors

Gene Therapy

Volumn 7, Issue 7, 2000, Pages 596-604

  Costello, E ^a,b   Munoz, M ^a   Buetti, E ^a   Meylan, P R A ^a   Diggelmann, H ^a   Thali, M ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

EGFP; Fibronectin; Gene therapy; Gene transfer; Lentiviral vector; T lymphocyte

Indexed keywords

CD28 ANTIGEN; FIBRONECTIN; GREEN FLUORESCENT PROTEIN; HEXADIMETHRINE BROMIDE; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; PHYTOHEMAGGLUTININ; PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER; CENTRIFUGATION; EMBRYO; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PRIORITY JOURNAL; RETROVIRUS; STEM CELL; SUPERNATANT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENE;

GIBBON APE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0034120890     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301135     Document Type: Article

References (37)

1. Rosenberg SA et al. Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl J Med 1990; 323: 570-578.
2. Morgan RA, Anderson WF. Human gene therapy. Annu Rev Biochem 1993; 62: 191-217.
3. Blaese RM et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995; 270: 475-480.
4. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature 1997; 389: 239-242.
5. Naldini L et al. In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 1996; 272: 263-267.
6. Blomer U et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997; 71: 6641-6649.
7. Kafri T et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 1997; 17: 314-317.
8. Gasmi M et al. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J Virol 1999; 73: 1828-1834.
9. Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 1998; 72: 811-816.
10. Zufferey R et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.
11. Dull T et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463-8471.
12. Zufferey R et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
13. Srinivasakumar N et al. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines. J Virol 1997; 71: 5841-5848.
14. White SM et al. Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 1999; 73: 2832-2840.
15. Corbeau P, Wong-Staal F. Anti-HIV effects of HIV vectors. Virology 1998; 243: 268-274.
16. Poznansky M et al. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J Virol 1991; 65: 532-536.
17. + cells by a recombinant human immunodeficiency virus retroviral vector. J Clin Invest 1991; 88: 1043-1047.
18. Corbeau P, Kraus G, Wong-Staal F. Efficient gene transfer by a human immunodeficiency virus type 1 (HIV-1)-derived vector utilizing a stable HIV packaging cell line. Proc Natl Acad Sci USA 1996; 93: 14070-14075.
19. Matsuoka H, Miyake K, Shimada T. Improved methods of HIV vector mediated gene transfer. Int J Hematol 1998; 67: 267-273.
20. Bunnell BA et al. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995; 92: 7739-7743.
21. Pollok KE et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction onrecombinant fibronectin fragments. J Virol 1998; 72: 4882-4892.
22. Fehse B et al. Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin. Br J Haematol 1998; 102: 566-574.
23. Dardalhon V et al. Green fluorescent protein as a selectable marker of fibronectin-facilitated retroviral gene transfer in primary human T lymphocytes. Hum Gene Ther 1999; 10: 5-14.
24. Case SS et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999; 96: 2988-2993.
25. Yang S et al. Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther 1999; 10: 123-132.
26. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
27. Quinn ER, Lum LG, Trevor KT. T cell activation modulates retrovirus-mediated gene expression. Hum Gene Ther 1998; 9: 1457-1467.
28. + cells via human immunodeficiency virus-based gene transfer vectors. Hum Gene Ther 1999; 10: 935-945.
29. Gabuzda DH et al. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages. J Acq Immun Def Syn 1994; 7: 908-915.
30. Inubushi R, Adachi A. Cell-dependent function of HIV-1 vif for virus replication. Int J Mol Med 1999; 3: 473-476.
31. Nascimbeni M et al. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J Gen Virol 1998; 79: 1945-1950.
32. Miller MD et al. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J Exp Med 1994; 179: 101-113.
33. Heinzinger NK et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 1994; 91: 7311-7315.
34. Zack JA. The role of the cell cycle in HIV-1 infection. Adv Exp Med Biol 1995; 374: 27-31.
35. Adra CN, Boer PH, McBurney MW. Cloning and expression of the mouse pgk-1 gene and the nudeotide sequence of its promoter. Gene 1987; 60: 65-74.
36. Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 1993; 90: 8392-8396.
37. Chen CA, Okayama H. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotecliniques 1988; 6: 632-638.